Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma-Reference-Cited by-同舟云学术

Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma

Published:2021-03 Issue: Volume:500 Page:182-193
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Casagrande Naike,Borghese Cinzia,Favero Andrea^ORCID,Vicenzetto Cristina^ORCID,Aldinucci Donatella^ORCID

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Systemic therapy in metastatic or unresectable well-differentiated/dedifferentiated liposarcoma;McGovern;Front Oncol,2017

2. FDA approval summary: trabectedin for unresectable or metastatic liposarcoma or leiomyosarcoma following an anthracycline-containing regimen;Barone;Clin. Cancer Res.,2017

3. The efficacy of trabectedin in treating ovarian cancer;Teplinsky;Expert. Opin. Pharmacother.,2017

4. Enriching cancer pharmacology with drugs of marine origin;Jimenez;Br. J. Pharmacol.,2020

5. Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms;Romano;Br. J. Cancer.,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to reprogram anti-inflammatory macrophages towards pro-inflammatory macrophages to support cancer immunotherapies;Immunology Letters;2024-06

2. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential;Biomedicine & Pharmacotherapy;2024-06

3. In ovarian cancer maraviroc potentiates the antitumoral activity and further inhibits the formation of a tumor-promoting microenvironment by trabectedin;Biomedicine & Pharmacotherapy;2024-03

4. In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869;Cells;2023-11-29

5. Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview;Cancers;2023-11-06